MetLife Investment Management, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$80,715
-25.1%
60,2350.0%0.00%0.0%
Q2 2023$107,821
-32.9%
60,235
+45.9%
0.00%0.0%
Q1 2023$160,591
+60.7%
41,283
+40.4%
0.00%0.0%
Q4 2022$99,940
-55.8%
29,394
-29.0%
0.00%
-50.0%
Q3 2022$226,093
+116.0%
41,409
+78.4%
0.00%
+100.0%
Q2 2022$104,691
-66.0%
23,213
-44.4%
0.00%
-50.0%
Q1 2022$307,860
+77.3%
41,772
+54.7%
0.00%
+100.0%
Q4 2021$173,655
+212.3%
27,007
+182.6%
0.00%0.0%
Q3 2021$55,610
-77.3%
9,555
-59.7%
0.00%
-50.0%
Q2 2021$244,718
-1.9%
23,7130.0%0.00%0.0%
Q1 2021$249,461
-48.8%
23,713
-24.7%
0.00%
-60.0%
Q4 2020$487,357
+6.0%
31,4830.0%0.01%0.0%
Q3 2020$459,652
-22.9%
31,4830.0%0.01%
-28.6%
Q2 2020$596,288
+20.6%
31,483
+22.3%
0.01%0.0%
Q1 2020$494,504
-12.5%
25,742
-12.6%
0.01%
+16.7%
Q4 2019$564,863
+99.3%
29,4660.0%0.01%
+100.0%
Q3 2019$283,463
+31.3%
29,466
+27.9%
0.00%0.0%
Q4 2018$215,950
-45.0%
23,0470.0%0.00%
-25.0%
Q3 2018$392,490
+0.1%
23,0470.0%0.00%
-20.0%
Q2 2018$392,000
+91.2%
23,047
+51.1%
0.01%
+150.0%
Q1 2018$205,000
+40.4%
15,2540.0%0.00%0.0%
Q4 2017$146,00015,2540.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$13,170,0009.51%
Palo Alto Investors LP 5,383,052$31,329,0001.89%
Birchview Capital, LP 246,000$1,432,0000.97%
Rubric Capital Management LP 3,375,758$19,647,0000.55%
Lombard Odier Asset Management (Switzerland) SA 1,517,804$8,834,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,401,861$8,159,0000.30%
AlphaCentric Advisors LLC 136,000$792,0000.20%
Bridgefront Capital, LLC 20,946$122,0000.13%
Hennion & Walsh Asset Management, Inc. 407,474$2,371,0000.12%
Virtus ETF Advisers LLC 44,364$258,0000.11%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders